Published in Theor Biol Med Model on December 30, 2011
Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules. Cell (2014) 1.79
Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Res (2012) 1.25
Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer Features. Front Oncol (2013) 0.99
Ovarian tumor attachment, invasion, and vascularization reflect unique microenvironments in the peritoneum: insights from xenograft and mathematical models. Front Oncol (2013) 0.93
Nonlinear growth kinetics of breast cancer stem cells: implications for cancer stem cell targeted therapy. Sci Rep (2013) 0.87
Microenvironmental variables must influence intrinsic phenotypic parameters of cancer stem cells to affect tumourigenicity. PLoS Comput Biol (2014) 0.87
Evolution and phenotypic selection of cancer stem cells. PLoS Comput Biol (2015) 0.85
A mathematical-biological joint effort to investigate the tumor-initiating ability of Cancer Stem Cells. PLoS One (2014) 0.79
A High-Performance Cellular Automaton Model of Tumor Growth with Dynamically Growing Domains. Appl Math (Irvine) (2014) 0.79
A multicompartment mathematical model of cancer stem cell-driven tumor growth dynamics. Bull Math Biol (2014) 0.77
Treatment Analysis in a Cancer Stem Cell Context Using a Tumor Growth Model Based on Cellular Automata. PLoS One (2015) 0.76
Cancer Stem Cell Plasticity as Tumor Growth Promoter and Catalyst of Population Collapse. Stem Cells Int (2015) 0.76
Stem Cell Plasticity And Niche Dynamics in Cancer Progression. IEEE Trans Biomed Eng (2016) 0.75
Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells. BMC Cancer (2016) 0.75
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
The serial cultivation of human diploid cell strains. Exp Cell Res (1961) 25.11
Telomeres shorten during ageing of human fibroblasts. Nature (1990) 23.97
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer (2008) 18.08
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell (1997) 13.34
A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol (1973) 7.28
A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol (1978) 6.45
Is cancer a disease of self-seeding? Nat Med (2006) 3.19
Telomere length, stem cells and aging. Nat Chem Biol (2007) 3.10
Cancer without disease. Nature (2004) 2.65
Role of telomeres and telomerase in cancer. Semin Cancer Biol (2011) 2.20
A cellular automaton model for tumour growth in inhomogeneous environment. J Theor Biol (2003) 1.81
Telomeres, telomerase, and aging: origin of the theory. Exp Gerontol (1998) 1.76
The universal dynamics of tumor growth. Biophys J (2003) 1.73
An evolutionary hybrid cellular automaton model of solid tumour growth. J Theor Biol (2007) 1.55
Traveling wave model to interpret a wound-healing cell migration assay for human peritoneal mesothelial cells. Tissue Eng (2004) 1.48
Migration rules: tumours are conglomerates of self-metastases. Br J Cancer (2009) 1.48
Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics. Cancer Res (2009) 1.46
A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype. J Theor Biol (2007) 1.37
The small intestine as a model for evaluating adult tissue stem cell drug targets. Cell Prolif (2003) 1.26
From single cells to tissue architecture-a bottom-up approach to modelling the spatio-temporal organisation of complex multi-cellular systems. J Math Biol (2008) 1.18
The inhibition of tumor growth by tumor mass. Cancer Res (1991) 1.18
Emerging patterns in tumor systems: simulating the dynamics of multicellular clusters with an agent-based spatial agglomeration model. J Theor Biol (2002) 1.18
Novel roles for telomerase in aging. Mech Ageing Dev (2006) 0.96
Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotype. Biol Direct (2010) 0.91
Quantitative modeling of tumor dynamics and radiotherapy. Acta Biotheor (2010) 0.89
Cyclical neutropenia and the peripheral control of white blood cell production. J Theor Biol (1998) 0.87
Telomere length analysis. Methods Mol Biol (2007) 0.87
Telomere length distribution. Digital image processing and statistical analysis. Methods Mol Biol (2002) 0.81
The effect of pressure on the growth of tumour cell colonies. J Theor Biol (2006) 0.81
Cancer stem cells as the engine of unstable tumor progression. J Theor Biol (2008) 0.81
Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst (2002) 3.77
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest (2002) 2.31
Endostatin's antiangiogenic signaling network. Mol Cell (2004) 1.95
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res (2009) 1.90
Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci U S A (2007) 1.85
SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. Cancer Res (2003) 1.53
Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics. Cancer Res (2009) 1.46
Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res (2003) 1.35
Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res (2010) 1.35
Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Res (2012) 1.25
Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis. FASEB J (2006) 1.21
Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis. J Theor Biol (2003) 1.16
Chromosomes are predominantly located randomly with respect to each other in interphase human cells. J Cell Biol (2002) 1.15
A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation. Radiat Environ Biophys (2009) 1.14
Molecular signaling network complexity is correlated with cancer patient survivability. Proc Natl Acad Sci U S A (2012) 1.13
A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach. Radiat Environ Biophys (2009) 1.11
Endostatin: the logic of antiangiogenic therapy. Drug Resist Updat (2005) 1.07
Biological effects of proton radiation: what we know and don't know. Radiat Res (2013) 1.06
Cancer stem cells in solid tumors: is 'evading apoptosis' a hallmark of cancer? Prog Biophys Mol Biol (2011) 1.01
Intercellular communication by exchange of cytoplasmic material via tunneling nano-tube like structures in primary human renal epithelial cells. PLoS One (2011) 1.00
Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype. PLoS One (2012) 0.99
Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer Features. Front Oncol (2013) 0.99
Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks. J Natl Cancer Inst (2006) 0.97
Second cancers after fractionated radiotherapy: stochastic population dynamics effects. J Theor Biol (2007) 0.96
An integrated multidisciplinary model describing initiation of cancer and the Warburg hypothesis. Theor Biol Med Model (2013) 0.95
The tumor growth paradox and immune system-mediated selection for cancer stem cells. Bull Math Biol (2012) 0.93
Phenotypic transition maps of 3D breast acini obtained by imaging-guided agent-based modeling. Integr Biol (Camb) (2011) 0.93
Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotype. Biol Direct (2010) 0.91
Systems biology and its potential role in radiobiology. Radiat Environ Biophys (2007) 0.90
Proton irradiation suppresses angiogenic genes and impairs cell invasion and tumor growth. Radiat Res (2012) 0.90
Prospective identification of glioblastoma cells generating dormant tumors. PLoS One (2012) 0.90
The emerging "hallmarks" of metabolic reprogramming and immune evasion: distinct or linked? Cancer Res (2013) 0.89
Modeling intercellular interactions during carcinogenesis. Radiat Res (2005) 0.89
Quantitative modeling of tumor dynamics and radiotherapy. Acta Biotheor (2010) 0.89
Age and space irradiation modulate tumor progression: implications for carcinogenesis risk. Radiat Res (2013) 0.87
Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion with systemic inflammation. PLoS One (2010) 0.87
Transcriptional changes induced by the tumor dormancy-associated microRNA-190. Transcription (2013) 0.87
Stochastic population dynamic effects for lung cancer progression. Radiat Res (2009) 0.86
Mathematical modeling of tumor growth and treatment. Curr Pharm Des (2014) 0.85
Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler Thromb Vasc Biol (2013) 0.85
Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy. Cancer Res (2013) 0.84
Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth. Theor Biol Med Model (2012) 0.83
Two Endogenous Antiangiogenic Inhibitors, Endostatin and Angiostatin, Demonstrate Biphasic Curves in their Antitumor Profiles. Dose Response (2010) 0.83
Center of cancer systems biology second annual workshop--tumor metronomics: timing and dose level dynamics. Cancer Res (2013) 0.83
Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy. Cancer Res (2012) 0.82
Quantitative modeling of chronic myeloid leukemia: insights from radiobiology. Blood (2012) 0.81
Formalizing an integrative, multidisciplinary cancer therapy discovery workflow. Cancer Res (2013) 0.81
Identification of stable endogenous control genes for transcriptional profiling of photon, proton and carbon-ion irradiated cells. Radiat Oncol (2012) 0.81
Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers. J Theor Biol (2013) 0.80
Multiple effects of β-amyloid on single excitatory synaptic connections in the PFC. Front Cell Neurosci (2013) 0.80
Antiangiogenic therapy and p53. Science (2002) 0.80
Using graph theory to describe and model chromosome aberrations. Radiat Res (2002) 0.80
Combined therapy with sonic hedgehog gene transfer and bone marrow-derived endothelial progenitor cells enhances angiogenesis and myogenesis in the ischemic skeletal muscle. J Vasc Res (2012) 0.80
The promoting role of a tumour-secreted chemorepellent in self-metastatic tumour progression. Math Med Biol (2010) 0.80
Chronic low dose-rate radiation down-regulates transcription related to mitosis and chromosomal movement similar to acute high dose in prostate cells. Int J Radiat Biol (2014) 0.79
A multicellular basis for the origination of blast crisis in chronic myeloid leukemia. Cancer Res (2011) 0.79
Cancer Therapy Targeting the HER2-PI3K Pathway: Potential Impact on the Heart. Front Pharmacol (2012) 0.79
Repopulation of interacting tumor cells during fractionated radiotherapy: stochastic modeling of the tumor control probability. Med Phys (2013) 0.78
Sonic hedgehog therapy in a mouse model of age-associated impairment of skeletal muscle regeneration. J Gerontol A Biol Sci Med Sci (2013) 0.78
Proton irradiation augments the suppression of tumor progression observed with advanced age. Radiat Res (2014) 0.77
A multicompartment mathematical model of cancer stem cell-driven tumor growth dynamics. Bull Math Biol (2014) 0.77
From concept to clinic: Mathematically informed immunotherapy. Curr Probl Cancer (2015) 0.75
Correction: Cardiovascular Risks Associated with Low Dose Ionizing Particle Radiation. PLoS One (2015) 0.75
Beyond the cancer cell: progression-level determinants highlight the multiscale nature of carcinogenesis risk. Cancer Res (2013) 0.75
Stochastic process pharmacodynamics: dose timing in neonatal gentamicin therapy as an example. AAPS J (2015) 0.75
Correction: Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants. PLoS One (2015) 0.75
A rapid-mutation approximation for cell population dynamics. Bull Math Biol (2009) 0.75
A robust procedure for removing background damage in assays of radiation-induced DNA fragment distributions. Radiat Res (2006) 0.75
TNF-TNFR2/p75 signaling inhibits early and increases delayed nontargeted effects in bone marrow-derived endothelial progenitor cells. J Biol Chem (2015) 0.75
SCHIP: statistics for chromosome interphase positioning based on interchange data. Bioinformatics (2005) 0.75
Subtraction of background damage in PFGE experiments on DNA fragment-size distributions. Radiat Environ Biophys (2007) 0.75